Skip to main content
Fig. 8 | Stem Cell Research & Therapy

Fig. 8

From: The utility of human fallopian tube mucosa as a novel source of multipotent stem cells for the treatment of autologous reproductive tract injury

Fig. 8

Comparison of in vitro production of growth factors and immunomodulatory cytokines from cultured cells. a Concentrations of vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) measured by using enzyme-linked immunoadsorbent assay (n = 3) are depicted. b Concentrations of interleukin-4 (IL-4), IL-6, tumor necrosis factor-alpha (TNF-α), TNF-β, and interferon-gamma (IFN-γ) measured by using enzyme-linked immunoadsorbent assay (n = 3) are depicted. hFMMSC, human fallopian tube mucosa mesenchymal stem cell; hFTMSC, human fallopian tube mesenchymal stem cell

Back to article page